Home

About The Program

Since the decoding of the human genome in 2002, there has been a rapid development in genetic testing technologies. Many countries have been competing to establish population genetic maps, represented by national genome program specialized for each country, such as the United Kingdom, Singapore, Japan, and others. The establishment of population genetic databases has a direct impact on monitoring genetic variants, allowing individuals to take preventive and preemptive measures before the onset of disease symptoms in many cases. In addition to the economic sustainability achieved through implementing health policies that are tailored according to the genetic makeup of populations.

Sustainable Development

The Kingdom of Bahrain has made strides in the implementation of the 2030 Agenda for Sustainable Development and the Sustainable Development Goals (SDGs).

Knowledge Center

If you wish to participate as an individual, you can log in with your Smart Key on the eGovernment portal and complete the online registration for the National Genome Program. After registration, you should visit the health center in your residential area, where the laboratory staff will collect a blood sample and confirm your participation in the program. The process is simple and convenient, requiring no prior appointment and no doctor’s consultation.

You can also participate in Genome Center campaigns, which are organized throughout the year in public spaces, shopping malls, conferences, and various events.

If you wish to participate as an institution, you can contact the National Genome Center team to arrange a visit to your organization’s premises, where the genome team will organize a special campaign for your institution.

To request an institutional campaign, please contact via email at: genome@health.gov.bh, or call:? 17-282240.

The Bahraini Genome Program is a survey research initiative that categorizes participants into different groups and phases. In the first phase, 6,000 samples have been analyzed in collaboration with Harvard University, USA. This initial collaboration is expected to be completed by the end of 2024. Participants will receive their individual results once the analysis and classification of findings are finalized by a team of specialized physicians. The team will first reach out to individuals whose results indicate the need for further follow-up and genetic counseling.

As for the second phase, 100,000 samples will be analyzed locally in progressive stages. The public will be regularly updated on the results and developments as they unfold.n through specialized term contracts.

The results of genome analysis are highly confidential, and participants will be personally contacted once their sample analysis is completed by the genome team.

Currently, the National Genome Center's projects are survey research initiatives. However, the center is committed to the responsibility of sharing results that indicate urgent health concerns for which preventive or proactive treatment plans are available.

View All FAQ